The Greatest Gift
is a Gift that keeps
on Giving...

Current Clinical Trials


  • A Phase III, randomized, open label study of the efficacy and safety of PF 02341066 versus standard of care chemotherapy (Premetrexed or Docetaxel) in patients with advanced non-small cell lung cancer (NSCLS)_ harboring a translocation or inversion event involving the Anaplastic Lymphoma Kinase (ALK) gene locus (A8081007)

  • Phase II Open-label single arm - study of the efficacy and safety of PF-02341066 in patients with advanced NSCLC harboring a translocation of inversion involving the Anaplastic Lymphoma Kinase (AIK) Gene Locus (A8081005)

  • A Phase III randomized, open label two-arm study of Neratinib in combination with Paclitaxel versus Trastuzumaeb plus Paclitaxel for treatment of Erb B-2 positive locally recurrent or metastatic breast cancer (314A2-3005-WW)


If questions about present study qualifications contact:
Donna McCallie, RN, MSN, OCN, CCRP
4801 South Congress Avenue, Suite 201
Lake Worth, FL 33461
Phone: 561-253-3980
Fax: 866-408-7995